A carregar...
The FDA Changed Everything
On May 23, 2017, the FDA approved the first cancer treatment (pembrolizumab) for any solid tumor with a specific genetic biomarker: microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR). For the first time in history, a solid cancer treatment was approved based on the genetic m...
Na minha lista:
| Publicado no: | Biomed Hub |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6945950/ https://ncbi.nlm.nih.gov/pubmed/31988934 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000481614 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|